BeOne Medicines (ONC) EBITDA Margin (2015 - 2026)
BeOne Medicines' EBITDA Margin was 21.44% in Q2 2026, up 12.05 percentage points from 9.39% a year earlier and up 2.21 percentage points from the prior quarter.
Powered by 
Analysis
BeOne Medicines (ONC) EBITDA Margin (2015 - 2026) Analysis & Trends
On a trailing twelve-month basis, BeOne Medicines' EBITDA Margin was 17.59% through Jun 30, 2026, up 15.63 percentage points year-over-year; for FY2025, it was 11.02%, up 21.42 percentage points from FY2024.
- EBITDA Margin has now increased for three consecutive years, with a five-year change of +537.41 percentage points (FY2020 to FY2025).
- In earlier years, EBITDA Margin was -10.40% in FY2024 (+35.15 pp), -45.55% in FY2023 (+76.16 pp), -121.71% in FY2022 (-3.35 pp) and -118.36% in FY2021 (+408.03 pp).
- The Q2 2026 figure marks the highest quarterly EBITDA Margin since Q3 2017.
- Compared with a year earlier, EBITDA Margin has increased for 17 straight quarters, with an average year-over-year change of +22.63 percentage points over the last eight quarters.
- The best year-over-year quarter for EBITDA Margin over five years was Q3 2021 (a gain of 256.03 percentage points); the worst was Q1 2022 (a drop of 152.33 percentage points).
- Per Business Quant data, ONC's EBITDA Margin in the three quarters before Q2 2026 was 19.23% (Q1 2026), 14.75% (Q4 2025) and 14.19% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 39.16% |
| 10 | BeOne Medicines | 41.22 Bn | 22.75 Bn | 1.53 Bn | 21.44% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.44% |
| Mar 31, 2026 | 19.23% |
| Dec 31, 2025 | 14.75% |
| Sep 30, 2025 | 14.19% |
| Jun 30, 2025 | 9.39% |
| Mar 31, 2025 | 3.93% |
| Dec 31, 2024 | -2.59% |
| Sep 30, 2024 | -4.89% |
| Jun 30, 2024 | -8.85% |
| Mar 31, 2024 | -31.40% |
| Dec 31, 2023 | -56.74% |
| Sep 30, 2023 | -14.39% |
| Jun 30, 2023 | -49.79% |
| Mar 31, 2023 | -78.44% |
| Dec 31, 2022 | -118.55% |
| Sep 30, 2022 | -108.91% |
| Jun 30, 2022 | -124.11% |
| Mar 31, 2022 | -139.16% |
| Dec 31, 2021 | -261.06% |
| Sep 30, 2021 | -218.05% |
API Access
BeOne Medicines EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ONC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ONC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ONC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();